Endo International PLC (ENDP)

ENDP (NASDAQ:Drugs) EQUITY
$50.99
neg -1.20
-2.40%
Today's Range: 50.98 - 53.26 | ENDP Avg Daily Volume: 3,628,300
Last Update: 02/10/16 - 3:59 PM EST
Volume: 2,640,575
YTD Performance: -14.70%
Open: $52.31
Previous Close: $52.22
52 Week Range: $46.66 - $96.58
Oustanding Shares: 226,449,346
Market Cap: 11,469,659,375
6-Month Chart
TheStreet Ratings Grade for ENDP
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 7 8 8 8
Moderate Buy 0 0 0 0
Hold 6 5 5 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.92 1.77 1.77 1.67
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: -11.06
Price Earnings Comparisons:
ENDP Sector Avg. S&P 500
-11.06 0.00 26.96
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-4.18% -34.28% 75.53%
GROWTH 12 Mo 3 Yr CAGR
Revenue 9.90 0.05 0.02
Net Income 0.00 -3.99 0.00
EPS 0.00 -4.05 0.00
Earnings for ENDP:
EBITDA 0.89B
Revenue 2.88B
Average Earnings Estimates
Qtr (12/15) Qtr (03/16) FY (12/15) FY (12/16)
Average Estimate $1.26 $1.31 $4.58 $5.95
Number of Analysts 9 4 4 13
High Estimate $1.34 $1.33 $4.60 $6.19
Low Estimate $1.11 $1.29 $4.55 $5.60
Prior Year $1.16 $1.17 $4.31 $4.58
Growth Rate (Year over Year) 8.81% 11.97% 6.15% 29.99%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Mylan and Endo International look like bargains at current prices.
These biotech/pharma picks could give you a very happy new year.
The company cleared an important hurdle last month.
Bearish
Oct 26, 2015 | 7:40 AM EDT
ENDP was removed from the Conviction Buy list, according to Goldman Sachs. $84 price target. Company is leveraged to sector headwinds.&...
Bearish
Sep 01, 2015 | 6:43 AM EDT
ENDP was downgraded from Overweight to Equal-weight, Morgan Stanley said. $85 price target. Company has limited long-term growth visibi...
Bullish
Jul 17, 2015 | 7:11 AM EDT
ENDP was upgraded from Outperform to Top Pick, RBC Capital said. $107 price target. Company is attractively valued and consensus number...
Acquisitions cut into overabundance of companies.
Endo Pharmaceuticals could offer a short-term play.
Bullish
Apr 13, 2015 | 8:15 AM EDT
Shares of ENDP now seen reaching $96, according to Deutsche Bank. Estimates also upped, as Xiaflex should drive growth. Buy rating.&nbs...
Take a look at some more of its recent moves.

Columnist Conversations

Juniper appears headed for a re test of major support near its 2015 low. With today's 1.5% loss JNPR is ...
$550 million to buy.
Spooking the markets now.
SPY $185.75 IWM $96.24

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.